A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergy 13 20 13 20 O
to 21 23 21 23 O
progesterone 24 36 24 36 B-allergy_name
or 37 39 37 39 O
estradiol 40 49 40 49 B-allergy_name
will 50 54 50 54 O
constitute 55 65 55 65 O
grounds 66 73 66 73 O

A 0 1 74 75 O
previous 2 10 76 84 O
diagnosis 11 20 85 94 O
of 21 23 95 97 O
diabetes 24 32 98 106 B-chronic_disease
, 32 33 106 107 O
a 34 35 108 109 O
fasting 36 43 110 117 B-clinical_variable
glucose 44 51 118 125 I-clinical_variable
â‰¥ 52 53 126 127 O
126 54 57 128 131 B-lower_bound
mg 58 60 132 134 I-lower_bound
/ 60 61 134 135 I-lower_bound
dl 61 63 135 137 I-lower_bound
, 63 64 137 138 O
or 65 67 139 141 O
a 68 69 142 143 O
hemoglobin 70 80 144 154 B-clinical_variable
A1c 81 84 155 158 I-clinical_variable
> 85 86 159 160 O
6.5 87 90 161 164 B-lower_bound
% 90 91 164 165 I-lower_bound

A 0 1 166 167 O
total 2 7 168 173 B-clinical_variable
testosterone 8 20 174 186 I-clinical_variable
> 21 22 187 188 O
150 23 26 189 192 B-lower_bound
ng 27 29 193 195 I-lower_bound
/ 29 30 195 196 I-lower_bound
dl 30 32 196 198 I-lower_bound
in 33 35 199 201 O
women 36 41 202 207 B-gender
with 42 46 208 212 O
PCOS 47 51 213 217 B-chronic_disease
( 52 53 218 219 O
which 53 58 219 224 O
suggests 59 67 225 233 O
the 68 71 234 237 O
possibility 72 83 238 249 O
of 84 86 250 252 O
a 87 88 253 254 O
virilizing 89 99 255 265 O
neoplasm 100 108 266 274 O
) 108 109 274 275 O

Abnormal 0 8 276 284 O
TSH 9 12 285 288 B-clinical_variable
( 13 14 289 290 O
subjects 14 22 290 298 O
with 23 27 299 303 O
adequately 28 38 304 314 O
treated 39 46 315 322 O
hypothyroidism 47 61 323 337 B-chronic_disease
, 61 62 337 338 O
reflected 63 72 339 348 O
by 73 75 349 351 O
normal 76 82 352 358 O
TSH 83 86 359 362 O
values 87 93 363 369 O

Abnormal 0 8 370 378 O
prolactin 9 18 379 388 B-clinical_variable
( 19 20 389 390 O
mild 20 24 390 394 O
elevations 25 35 395 405 O
may 36 39 406 409 O
be 40 42 410 412 O
seen 43 47 413 417 O
in 48 50 418 420 O
PCOS 51 55 421 425 B-chronic_disease
, 55 56 425 426 O
and 57 60 427 430 O
elevations 61 71 431 441 O
< 72 73 442 443 O
1.5 74 77 444 447 B-upper_bound
times 78 83 448 453 I-upper_bound
the 84 87 454 457 I-upper_bound
upper 88 93 458 463 I-upper_bound
limit 94 99 464 469 I-upper_bound
of 100 102 470 472 I-upper_bound
normal 103 109 473 479 I-upper_bound
will 110 114 480 484 O
be 115 117 485 487 O
accepted 118 126 488 496 O
in 127 129 497 499 O
this 130 134 500 504 O
group 135 140 505 510 O
) 140 141 510 511 O
( 142 143 512 513 O
confirmed 143 152 513 522 O
on 153 155 523 525 O
repeat 156 162 526 532 O
) 162 163 532 533 O

Abnormal 0 8 534 542 O
sodium 9 15 543 549 O
or 16 18 550 552 O
potassium 19 28 553 562 O
concentrations 29 43 563 577 O
( 44 45 578 579 O
confirmed 45 54 579 588 O
on 55 57 589 591 O
repeat 58 64 592 598 O
) 64 65 598 599 O
; 65 66 599 600 O
bicarbonate 67 78 601 612 B-clinical_variable
concentrations 79 93 613 627 I-clinical_variable
< 94 95 628 629 O
20 95 97 629 631 B-upper_bound
or 98 100 632 634 O
> 101 102 635 636 O
30 102 104 636 638 B-lower_bound
( 105 106 639 640 O
confirmed 106 115 640 649 O
on 116 118 650 652 O
repeat 119 125 653 659 O
) 125 126 659 660 O

Due 0 3 661 664 O
to 4 6 665 667 O
the 7 10 668 671 O
amount 11 17 672 678 O
of 18 20 679 681 O
blood 21 26 682 687 O
being 27 32 688 693 O
drawn 33 38 694 699 O
in 39 41 700 702 O
the 42 45 703 706 O
study 46 51 707 712 O
, 51 52 712 713 O
subjects 53 61 714 722 O
with 62 66 723 727 O
body 67 71 728 732 B-clinical_variable
weight 72 78 733 739 I-clinical_variable
< 79 80 740 741 O
110 81 84 742 745 B-upper_bound
lbs 85 88 746 749 I-upper_bound

Elevated 0 8 750 758 O
DHEAS 9 14 759 764 O
( 15 16 765 766 O
mild 16 20 766 770 O
elevations 21 31 771 781 B-clinical_variable
may 32 35 782 785 O
be 36 38 786 788 O
seen 39 43 789 793 O
in 44 46 794 796 O
PCOS 47 51 797 801 B-chronic_disease
, 51 52 801 802 O
and 53 56 803 806 O
elevations 57 67 807 817 O
< 68 69 818 819 O
1.5 70 73 820 823 B-upper_bound
times 74 79 824 829 I-upper_bound
the 80 83 830 833 O
upper 84 89 834 839 B-clinical_variable
limit 90 95 840 845 I-clinical_variable
of 96 98 846 848 I-clinical_variable
normal 99 105 849 855 I-clinical_variable
will 106 110 856 860 O
be 111 113 861 863 O
accepted 114 122 864 872 O
in 123 125 873 875 O
PCOS 126 130 876 880 O
) 130 131 880 881 O

Evidence 0 8 882 890 O
of 9 11 891 893 O
Cushing 12 19 894 901 B-chronic_disease
's 19 21 901 903 I-chronic_disease
syndrome 22 30 904 912 I-chronic_disease
by 31 33 913 915 O
history 34 41 916 923 O
or 42 44 924 926 O
physical 45 53 927 935 O
exam 54 58 936 940 O

Follicular 0 10 941 951 B-clinical_variable
17 11 13 952 954 I-clinical_variable
- 13 14 954 955 I-clinical_variable
hydroxyprogesterone 14 33 955 974 I-clinical_variable
> 34 35 975 976 O
300 36 39 977 980 B-lower_bound
ng 40 42 981 983 I-lower_bound
/ 42 43 983 984 I-lower_bound
dl 43 45 984 986 I-lower_bound
, 45 46 986 987 O
which 47 52 988 993 O
suggests 53 61 994 1002 O
the 62 65 1003 1006 O
possibility 66 77 1007 1018 O
of 78 80 1019 1021 O
congenital 81 91 1022 1032 B-chronic_disease
adrenal 92 99 1033 1040 I-chronic_disease
hyperplasia 100 111 1041 1052 I-chronic_disease

If 0 2 1053 1055 O
they 3 7 1056 1060 O
remain 8 14 1061 1067 O
anemic 15 21 1068 1074 B-chronic_disease
after 22 27 1075 1080 O
2 28 29 1081 1082 B-lower_bound
sequential 30 40 1083 1093 I-lower_bound
months 41 47 1094 1100 I-lower_bound
of 48 50 1101 1103 O
ferrous 51 58 1104 1111 B-treatment
gluconate 59 68 1112 1121 I-treatment
( 69 70 1122 1123 I-treatment
325 70 73 1123 1126 I-treatment
mg 74 76 1127 1129 I-treatment
bid 77 80 1130 1133 I-treatment
) 80 81 1133 1134 I-treatment

Pregnant 0 8 1135 1143 B-pregnancy

Subjects 0 8 1144 1152 O
will 9 13 1153 1157 O
be 14 16 1158 1160 O
18 17 19 1161 1163 B-lower_bound
- 19 20 1163 1164 O
35 20 22 1164 1166 B-upper_bound
years 23 28 1167 1172 I-upper_bound
old 29 32 1173 1176 O

Subjects 0 8 1177 1185 O
will 9 13 1186 1190 O
be 14 16 1191 1193 O
healthy 17 24 1194 1201 O
women 25 30 1202 1207 B-gender

Subjects 0 8 1208 1216 O
will 9 13 1217 1221 O
be 14 16 1222 1224 O
willing 17 24 1225 1232 O
to 25 27 1233 1235 O
strictly 28 36 1236 1244 O
avoid 37 42 1245 1250 O
pregnancy 43 52 1251 1260 B-pregnancy
( 53 54 1261 1262 O
using 54 59 1262 1267 B-contraception_consent
non 60 63 1268 1271 I-contraception_consent
- 63 64 1271 1272 I-contraception_consent
hormonal 64 72 1272 1280 I-contraception_consent
methods 73 80 1281 1288 I-contraception_consent
) 80 81 1288 1289 O
during 82 88 1290 1296 O
the 89 92 1297 1300 O
time 93 97 1301 1305 O
of 98 100 1306 1308 O
study 101 106 1309 1314 O
and 107 110 1315 1318 O
must 111 115 1319 1323 O
be 116 118 1324 1326 O
willing 119 126 1327 1334 O
and 127 130 1335 1338 O
able 131 135 1339 1343 O
to 136 138 1344 1346 O
provide 139 146 1347 1354 O
informed 147 155 1355 1363 O
consent 156 163 1364 1371 O

Virilization 0 12 1372 1384 B-chronic_disease

Women 0 5 1385 1390 B-gender
with 6 10 1391 1395 O
a 11 12 1396 1397 O
BMI 13 16 1398 1401 B-bmi
greater 17 24 1402 1409 O
or 25 27 1410 1412 O
equal 28 33 1413 1418 O
to 34 36 1419 1421 O
40 37 39 1422 1424 B-lower_bound
kg 40 42 1425 1427 I-lower_bound
/ 42 43 1427 1428 I-lower_bound
m2 43 45 1428 1430 I-lower_bound

Women 0 5 1431 1436 B-gender
with 6 10 1437 1441 O
a 11 12 1442 1443 O
history 13 20 1444 1451 O
of 21 23 1452 1454 O
any 24 27 1455 1458 O
disorders 28 37 1459 1468 O
that 38 42 1469 1473 O
may 43 46 1474 1477 O
potentially 47 58 1478 1489 O
be 59 61 1490 1492 O
complicated 62 73 1493 1504 O
by 74 76 1505 1507 O
long 77 81 1508 1512 O
- 81 82 1512 1513 O
term 82 86 1513 1517 O
iron 87 91 1518 1522 B-treatment
supplementation 92 107 1523 1538 I-treatment
, 107 108 1538 1539 O
such 109 113 1540 1544 O
as 114 116 1545 1547 O
hemochromatosis 117 132 1548 1563 B-treatment
and 133 136 1564 1567 O
polycythemia 137 149 1568 1580 B-treatment
vera 150 154 1581 1585 I-treatment

Women 0 5 1586 1591 B-gender
with 6 10 1592 1596 O
a 11 12 1597 1598 O
significant 13 24 1599 1610 O
history 25 32 1611 1618 O
of 33 35 1619 1621 O
cardiac 36 43 1622 1629 B-chronic_disease
or 44 46 1630 1632 O
pulmonary 47 56 1633 1642 B-chronic_disease
dysfunction 57 68 1643 1654 I-chronic_disease
( 69 70 1655 1656 O
e.g. 70 74 1656 1660 O
, 74 75 1660 1661 O
known 76 81 1662 1667 O
or 82 84 1668 1670 O
suspected 85 94 1671 1680 O
congestive 95 105 1681 1691 B-chronic_disease
heart 106 111 1692 1697 I-chronic_disease
failure 112 119 1698 1705 I-chronic_disease
; 119 120 1705 1706 O
known 121 126 1707 1712 O
or 127 129 1713 1715 O
suspected 130 139 1716 1725 O
coronary 140 148 1726 1734 B-chronic_disease
atherosclerosis 149 164 1735 1750 I-chronic_disease
; 164 165 1750 1751 O
asthma 166 172 1752 1758 B-chronic_disease
requiring 173 182 1759 1768 O
systemic 183 191 1769 1777 B-treatment
intermittent 192 204 1778 1790 I-treatment
corticosteroids 205 220 1791 1806 O
; 220 221 1806 1807 O
etc 222 225 1808 1811 O
. 225 226 1811 1812 O
) 226 227 1812 1813 O

Women 0 5 1814 1819 B-gender
with 6 10 1820 1824 O
abnormal 11 19 1825 1833 B-chronic_disease
renal 20 25 1834 1839 I-chronic_disease
function 26 34 1840 1848 I-chronic_disease

Women 0 5 1849 1854 B-gender
with 6 10 1855 1859 O
anemia 11 17 1860 1866 B-chronic_disease
( 18 19 1867 1868 O
hematocrit 19 29 1868 1878 B-clinical_variable
< 30 31 1879 1880 O
36 32 34 1881 1883 B-upper_bound
% 34 35 1883 1884 I-upper_bound
and/or 36 42 1885 1891 O
a 43 44 1892 1893 O
hemoglobin 45 55 1894 1904 B-clinical_variable
level 56 61 1905 1910 I-clinical_variable
< 62 63 1911 1912 O
12 63 65 1912 1914 B-upper_bound
g 66 67 1915 1916 I-upper_bound
/ 67 68 1916 1917 I-upper_bound
dl 68 70 1917 1919 I-upper_bound
) 70 71 1919 1920 O
will 72 76 1921 1925 O
be 77 79 1926 1928 O
treated 80 87 1929 1936 O
with 88 92 1937 1941 O
iron 93 97 1942 1946 B-treatment
for 98 101 1947 1950 O
a 102 103 1951 1952 O
maximum 104 111 1953 1960 O
of 112 114 1961 1963 O
2 115 116 1964 1965 B-clinical_variable
sequential 117 127 1966 1976 I-clinical_variable
months 128 134 1977 1983 I-clinical_variable
before 135 141 1984 1990 O
the 142 145 1991 1994 O
1st 146 149 1995 1998 O
admission 150 159 1999 2008 O
and/or 160 166 2009 2015 O
before 167 173 2016 2022 O
the 174 177 2023 2026 O
2nd 178 181 2027 2030 O
admission 182 191 2031 2040 O

Women 0 5 2041 2046 B-gender
with 6 10 2047 2051 O
liver 11 16 2052 2057 B-clinical_variable
enzymes 17 24 2058 2065 I-clinical_variable
, 24 25 2065 2066 O
alkaline 26 34 2067 2075 B-clinical_variable
phosphatase 35 46 2076 2087 I-clinical_variable
, 46 47 2087 2088 O
or 48 50 2089 2091 O
bilirubin 51 60 2092 2101 B-clinical_variable
> 61 62 2102 2103 O
1.5 63 66 2104 2107 B-lower_bound
times 67 72 2108 2113 I-lower_bound
upper 73 78 2114 2119 I-lower_bound
limit 79 84 2120 2125 I-lower_bound
of 85 87 2126 2128 I-lower_bound
normal 88 94 2129 2135 I-lower_bound
( 95 96 2136 2137 O
confirmed 96 105 2137 2146 O
on 106 108 2147 2149 O
repeat 109 115 2150 2156 O
) 115 116 2156 2157 O

breast 0 6 2158 2164 O
- 6 7 2164 2165 O
feeding 7 14 2165 2172 O
women 15 20 2173 2178 B-gender

if 0 2 2179 2181 O
elevated 3 11 2182 2190 O
during 12 18 2191 2197 O
the 19 22 2198 2201 O
luteal 23 29 2202 2208 O
phase 30 35 2209 2214 O
and 36 39 2215 2218 O
there 40 45 2219 2224 O
is 46 48 2225 2227 O
a 49 50 2228 2229 O
concern 51 58 2230 2237 O
about 59 64 2238 2243 O
the 65 68 2244 2247 O
possibility 69 80 2248 2259 O
of 81 83 2260 2262 O
congenital 84 94 2263 2273 B-chronic_disease
adrenal 95 102 2274 2281 I-chronic_disease
hyperplasia 103 114 2282 2293 I-chronic_disease
, 114 115 2293 2294 O
the 116 119 2295 2298 O
17 120 122 2299 2301 O
- 122 123 2301 2302 O
hydroxyprogesterone 123 142 2302 2321 O
may 143 146 2322 2325 O
be 147 149 2326 2328 O
collected 150 159 2329 2338 O
during 160 166 2339 2345 O
the 167 170 2346 2349 O
follicular 171 181 2350 2360 O
phase 182 187 2361 2366 O
, 187 188 2366 2367 O
or 189 191 2368 2370 O
> 192 193 2371 2372 O
60 193 195 2372 2374 B-lower_bound
if 196 198 2375 2377 O
oligomenorrheic 199 214 2378 2393 B-chronic_disease

serum 0 5 2394 2399 B-clinical_variable
creatinine 6 16 2400 2410 I-clinical_variable
> 17 18 2411 2412 O
1.4 19 22 2413 2416 B-lower_bound

women 0 5 2417 2422 B-gender
with 6 10 2423 2427 O
PCOS 11 15 2428 2432 B-chronic_disease
( 16 17 2433 2434 O
defined 17 24 2434 2441 O
as 25 27 2442 2444 O
clinical 28 36 2445 2453 O
/ 36 37 2453 2454 O
biochemical 37 48 2454 2465 O
evidence 49 57 2466 2474 O
of 58 60 2475 2477 O
hyperandrogenism 61 77 2478 2494 B-chronic_disease
plus 78 82 2495 2499 O
oligomenorrhea 83 97 2500 2514 B-chronic_disease
, 97 98 2514 2515 O
but 99 102 2516 2519 O
with 103 107 2520 2524 O
no 108 110 2525 2527 O
evidence 111 119 2528 2536 O
for 120 123 2537 2540 O
other 124 129 2541 2546 O
endocrinopathies 130 146 2547 2563 B-chronic_disease
) 146 147 2563 2564 O

women 0 5 2565 2570 B-gender
with 6 10 2571 2575 O
a 11 12 2576 2577 O
history 13 20 2578 2585 O
of 21 23 2586 2588 O
any 24 27 2589 2592 O
disorders 28 37 2593 2602 O
that 38 42 2603 2607 O
may 43 46 2608 2611 O
potentially 47 58 2612 2623 O
be 59 61 2624 2626 O
complicated 62 73 2627 2638 O
by 74 76 2639 2641 O
hormonal 77 85 2642 2650 B-clinical_variable
treatment 86 95 2651 2660 I-clinical_variable
, 95 96 2660 2661 O
such 97 101 2662 2666 O
as 102 104 2667 2669 O
DVT 105 108 2670 2673 B-chronic_disease
and 109 112 2674 2677 O
breast 113 119 2678 2684 B-cancer
, 119 120 2684 2685 O
ovarian 121 128 2686 2693 B-cancer
, 128 129 2693 2694 O
or 130 132 2695 2697 O
endometrial 133 144 2698 2709 B-cancer
cancer 145 151 2710 2716 I-cancer

women 0 5 2717 2722 B-gender
with 6 10 2723 2727 O
any 11 14 2728 2731 O
other 15 20 2732 2737 O
cancer 21 27 2738 2744 B-cancer
diagnosis 28 37 2745 2754 O
and/or 38 44 2755 2761 O
treatment 45 54 2762 2771 B-treatment
( 55 56 2772 2773 O
with 56 60 2773 2777 O
the 61 64 2778 2781 O
exception 65 74 2782 2791 O
of 75 77 2792 2794 O
basal 78 83 2795 2800 B-cancer
cell 84 88 2801 2805 I-cancer
or 89 91 2806 2808 O
squamous 92 100 2809 2817 B-cancer
skin 101 105 2818 2822 I-cancer
carcinoma 106 115 2823 2832 I-cancer
) 115 116 2832 2833 O
unless 117 123 2834 2840 O
they 124 128 2841 2845 O
have 129 133 2846 2850 O
remained 134 142 2851 2859 O
clinically 143 153 2860 2870 O
disease 154 161 2871 2878 O
free 162 166 2879 2883 O
( 167 168 2884 2885 O
based 168 173 2885 2890 O
on 174 176 2891 2893 O
appropriate 177 188 2894 2905 O
surveillance 189 201 2906 2918 O
) 201 202 2918 2919 O
for 203 206 2920 2923 O
five 207 211 2924 2928 B-upper_bound
years 212 217 2929 2934 I-upper_bound

women 0 5 2935 2940 B-gender
with 6 10 2941 2945 O
regular 11 18 2946 2953 O
menstrual 19 28 2954 2963 O
cycles 29 35 2964 2970 O
and 36 39 2971 2974 O
no 40 42 2975 2977 O
evidence 43 51 2978 2986 O
of 52 54 2987 2989 O
hyperandrogenism 55 71 2990 3006 B-chronic_disease

